KalVista Pharma

KALV

27.0000.00% ( 0.000 )

Delisted: Jun 15, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Overview: KalVista Pharma(KALV) the Revenue is 40.86 M (--%);the EBIT is -23.44 M (+52.84%);the EPS is -0.43 (+55.95%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

0.04B--

----

----

EBIT

-0.02B52.84%

----

----

EPS

-0.430355.95%

----

----

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly